NCT06187025Recruiting
Addiction & Stroke
Addiction in the Secondary Prevention of Stroke
Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Modifiable stroke risk-factors, which include poor lifestyle habits, account for 90 % of the risk of stroke. Disability Adjusted Life Years (DALYs) related to cerebrovascular disorders rely on three main factors, including the severity of stroke-related symptoms, the occurrence of stroke complications, and stroke recurrences. Stroke complications and the risk of stroke recurrence are highly dependent on the control of vascular risk factors. Thus, the secondary prevention of stroke involves profound lifestyle modifications including substance use cessation and diet changes.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 15 Dec 2023
- Start date
- 7 Feb 2024
- Primary completion date
- 7 Aug 2026
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Stroke
- NCT number
- NCT06187025
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 7 Feb 2024 to the primary completion date, 7 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subarachnoid hemorrhage; Dementia syndrome or other neurologic disorder;
- Severe aphasia (NIHSS item 9 ≥ 2) and/or Severe visual impairment interfering with the completion of evaluations;
Other
- Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
- Pregnancy or breastfeeding;
- Inability to read French;
- Individuals under legal protection or unable to personally express their consent
- Participation in another protocol modifying the patient's follow-up status
Who the study is looking for
- Male or female
- At least 18 years of age and younger than 80 years;
- Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an ABCD2 score ≥ 4;
- Returning to the Bordeaux Hospital neurovascular unit for the standard care 3-months post-stroke follow-up visit;
- National Institute Health Stroke Scale (NIHSS) \< 15;
- modified Rankin scale ≤ 4;
- No severe cognitive impairment as defined by the neurologist;
- Written informed consent by the patient;
- Coverage by the French National Health Insurance.
- For the feasibility study assessing the acceptability of the eHealth device to optimize stroke secondary prevention, additional inclusion criteria will be the ability to use a smartphone and living in an area with internet coverage.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.